REQUEST A DEMO
Total
USD $0.00
Search more companies

GUP Apteka N 1 (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: GUP Apteka N 1 Profile Updated: August 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Russian Download a sample report

GUP Apteka N 1 is an enterprise based in Russia. Its main office is in Tver. It operates in the Pharmacies and Drug Stores industry. GUP Apteka N 1 was incorporated on December 04, 2002. In 2022, the company reported a net sales revenue increase of 3.67%. Its’ total assets recorded a growth of 2.02%. The net profit margin of GUP Apteka N 1 increased by 0.36% in 2022.

Headquarters
Chaikovskogo, 31
Tver; Tver Oblast; Postal Code: 170002

Contact Details: Purchase the GUP Apteka N 1 report to view the information.

Website: http://apteka1-tver.ru

Basic Information
Outstanding Shares:
Purchase the GUP Apteka N 1 report to view the information.
Registered Capital:
Purchase the GUP Apteka N 1 report to view the information.
Incorporation Date:
December 04, 2002
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Assotsiatsiya Apteki Goroda Tveri
Company Performance
Financial values in the chart are available after GUP Apteka N 1 report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
3.67%
Total operating revenue
3.67%
Operating profit (EBIT)
54.75%
Net Profit (Loss) for the Period
85.98%
Total assets
2.02%
Total equity
8.54%
Operating Profit Margin (ROS)
0.67%
Net Profit Margin
0.36%
Return on Equity (ROE)
7.01%
Quick Ratio
-0.01%
Cash Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?